Related Experiment Video
Updated: Jun 2, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including
Kui Lin1, James R Taylor, Thomas D Wu
1Genentech, South San Francisco, California, United States of America. klin@gene.com
Background:
TMEFF2 is a protein containing a single EGF-like domain and two follistatin-like modules. The biological function of TMEFF2 remains unclear with conflicting reports suggesting both a positive and a negative association between TMEFF2 expression and human cancers.
Methodology/Principal Findings:
Here we report that the extracellular domain of TMEFF2 interacts with PDGF-AA. This interaction requires the amino terminal region of the extracellular domain containing the follistatin modules and cannot be mediated by the EGF-like domain alone. Furthermore, the extracellular domain of TMEFF2 interferes with PDGF-AA-stimulated fibroblast proliferation in a dose-dependent manner. TMEFF2 expression is downregulated in human brain cancers and is negatively correlated with PDGF-AA expression. Suppressed expression of TMEFF2 is associated with its hypermethylation in several human tumor types, including glioblastoma and cancers of ovarian, rectal, colon and lung origins. Analysis of glioma subtypes indicates that TMEFF2 hypermethylation and decreased expression are associated with a subset of non-Proneural gliomas that do not display CpG island methylator phentoype.
Conclusions/Significance:
These data provide the first evidence that TMEFF2 can function to regulate PDGF signaling and that it is hypermethylated and downregulated in glioma and several other cancers, thereby suggesting an important role for this protein in the etiology of human cancers.
Insights
The TMEFF2 protein regulates PDGF signaling and is downregulated in human cancers due to hypermethylation. This suggests TMEFF2 plays a role in cancer development.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- TMEFF2 (a protein with EGF-like and follistatin modules) has an unclear role in human cancers.
- Conflicting reports exist regarding TMEFF2's association with cancer.
- This study investigates TMEFF2's function and its role in cancer etiology.
Purpose of the Study:
- To elucidate the biological function of the TMEFF2 protein.
- To investigate the interaction of TMEFF2 with PDGF-AA.
- To determine the role of TMEFF2 in human cancers, particularly brain tumors.
Main Methods:
- Investigated the interaction between the extracellular domain of TMEFF2 and PDGF-AA.
- Assessed the effect of TMEFF2 on PDGF-AA-stimulated fibroblast proliferation.
- Analyzed TMEFF2 expression, hypermethylation, and correlation with PDGF-AA in various human cancers, including gliomas.
Main Results:
- The extracellular domain of TMEFF2 interacts with PDGF-AA, mediated by its follistatin modules.
- TMEFF2 inhibits PDGF-AA-stimulated fibroblast proliferation.
- TMEFF2 is downregulated and hypermethylated in human brain cancers and other tumor types, negatively correlating with PDGF-AA expression.
Conclusions:
- TMEFF2 regulates PDGF signaling, indicating a functional role in cell proliferation.
- TMEFF2 is frequently hypermethylated and downregulated in multiple human cancers, including glioma.
- These findings suggest TMEFF2 is important in the development of human cancers.
Related Concept Videos
Master Transcription Regulators
Mitogens and the Cell Cycle
TGF - β Signaling Pathway
The Tumor Microenvironment
The Tumor Microenvironment
Abnormal Proliferation
